Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Agreed creating and cultivating shareholder value has always been paramount to CEO Odidi.

And even when faced with the untimely completely stalled generics approvals over the past 3 full years he never once wavered and took the easy dilution way out.

In fact he did the exact opposite by trying his best to stave off any raises as long as he could while simultaneously trying to secure more partnership and/or licensing agreements that would solve the 3 year FDA delays on granting them any further ANDA approvals due to the FDA's own insane generics backlog that had nothing to do with IPCI.

The best part about the long drawn out FDA ANDA delayed approvals is that all of them should now be arriving like clockwork over the course of the next calendar year...which will provide IPCI with several market boosting events on top of their next Rexista, PODRAS and Regabatin catalysts.

So the next 2 years will more than make up for the past 2 years of being stalled waiting for FDA ANDA approvals the majority of us thought would've arrived by now glta